| 51 |
19285926 | Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography/tandem mass spectrometry. | 2009 Apr 1 |
1 |
| 52 |
19457254 | Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. | 2009 May 20 |
1 |
| 53 |
19780597 | Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues. | 2009 Oct |
2 |
| 54 |
20055166 | [Research progress of neuraminidase inhibitors for anti-influenza]. | 2009 Sep |
1 |
| 55 |
18727441 | Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses. | 2008 |
1 |
| 56 |
17112602 | Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. | 2007 Mar |
1 |
| 57 |
17703908 | REMOVED: Physicochemical properties of the potent influenza neuraminidase inhibitor, peramivir (BCX-1812). | 2007 Jul 10 |
2 |
| 58 |
17109288 | Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. | 2006 Dec 15 |
1 |
| 59 |
16430195 | Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. | 2005 |
1 |
| 60 |
12919021 | Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents. | 2003 Aug 22 |
1 |